Name | 5-Chloro-N-({(5S)-2-oxo-3-[4-(2-oxo-1(2H)-pyridinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide |
---|---|
Synonyms |
5-Chloro-N-({(5S)-2-oxo-3-[4-(2-oxo-1(2H)-pyridinyl)phenyl]-1,3-oxazolidin-5-yl}methyl)-2-thiophenecarboxamide
2-Thiophenecarboxamide, 5-chloro-N-[[(5S)-2-oxo-3-[4-(2-oxo-1(2H)-pyridinyl)phenyl]-5-oxazolidinyl]methyl]- |
Description | Zifaxaban is a novel, potent, selective, direct and oral factor Xa inhibitor with IC50 of 11.1 nM (human FXa), displays > 10,000-fold selectivity than other serine proteases; also deoes not impair platelet aggregation induced by collagen, adenosine diphosphate (ADP) or arachidonic acid; significantly prolongs clotting time, prothrombin time (PT), and activated partial thromboplastin time (APTT) in the plasma of humans, rabbits, and rats, with a relatively weak effect on thrombin time; strongly suppresses thrombus formation with ED50 values of 3.09 mg/kg in venous thrombosis models in rats. |
---|---|
References | References 1. Qiu X, et al. Eur J Pharmacol. 2018 Aug 17. pii: S0014-2999(18)30469-2. View Related Products by Target Factor Xa |
Density | 1.5±0.1 g/cm3 |
---|---|
Boiling Point | 680.2±55.0 °C at 760 mmHg |
Molecular Formula | C20H16ClN3O4S |
Molecular Weight | 429.877 |
Flash Point | 365.2±31.5 °C |
Exact Mass | 429.054993 |
LogP | 2.45 |
Vapour Pressure | 0.0±2.1 mmHg at 25°C |
Index of Refraction | 1.663 |